BiotechTube

Sertaconazole nitrate cream 2%

Phase 3UNKNOWN
0 views this week 0 watching💤 Quiet
Interest: 36/100
36
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Tinea Pedis

Conditions

Tinea Pedis, Athlete's Foot, Foot Fungus, Ringworm

Trial Timeline

Mar 1, 2009 → Sep 1, 2009

NCT ID
NCT00856596

About Sertaconazole nitrate cream 2%

Sertaconazole nitrate cream 2% is a phase 3 stage product being developed by Johnson & Johnson for Tinea Pedis. The current trial status is unknown. This product is registered under clinical trial identifier NCT00856596. Target conditions include Tinea Pedis, Athlete's Foot, Foot Fungus.

What happened to similar drugs?

3 of 10 similar drugs in Tinea Pedis were approved

Approved (3) Terminated (1) Active (6)
❌Placebo cream + Ketoconazole 2% cream (formulation F012) (Nizoral) + Ketoconazole 2% cream (formulation F126)Johnson & JohnsonPhase 3
🔄Terbinafine hydrochloride (HCl) + GriseofulvinNovartisPhase 3
🔄Terbinafine + Terbinafine PlaceboNovartisPhase 3
🔄Terbinafine hydrochlorideNovartisPhase 3
🔄fluconazolePfizerPhase 3
🔄Econazole Nitrate Cream, 1% + PlaceboViatrisPhase 3
✅Luliconazole Cream 1% + Vehicle CreamBausch HealthApproved

Hype Score Breakdown

Clinical
17
Activity
4
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00856596Phase 3UNKNOWN

Competing Products

20 competing products in Tinea Pedis

See all competitors
ProductCompanyStageHype Score
Butenafine Hydrochloride 1% + Butenafine Hydrochloride 1% B + Butenafine Hydrochloride 1% + Vehicle A + Vehicle BSun PharmaceuticalPhase 1
21
Naftifine Hydrochloride Gel 2% + Naftin® Gel 2% + Placebo Topical GelSun PharmaceuticalPhase 1
29
Naftifine Hydrochloride Cream 2% + Naftin® (Naftifine Hydrochloride) Cream 2% + Placebo Topical CreamSun PharmaceuticalPhase 1
29
Butenafine Hydrochloride Cream, 1% + Lotrimin Ultra® + Butenafine VehicleSun PharmaceuticalPhase 1
29
Naftifine HCl Cream 1% + Naftin® (Naftifine HCl) Cream 1% + Placebo topical creamSun PharmaceuticalPhase 1
29
Ketoconazole Shampoo, 2% + Ketoconazole Shampoo, 2% (Reference Standard) + PlaceboSun PharmaceuticalPhase 1
29
TA103 + Placebo ControlSun PharmaceuticalPhase 1
29
Oxiconazole Nitrate Cream 1% + Oxiconazole Nitrate Cream 1% (Oxistat®) + PlaceboSun PharmaceuticalPhase 1
29
Butenafine cream 1% manufactured by Taro + Lotrimin Ultra (butenafine) 1% + Butenafine Vehicle manufactured by TaroSun PharmaceuticalPhase 1
29
Placebo cream + Ketoconazole 2% cream (formulation F012) (Nizoral) + Ketoconazole 2% cream (formulation F126)Johnson & JohnsonPhase 3
32
Terbinafine hydrochloride (HCl) + GriseofulvinNovartisPhase 3
40
Terbinafine + Terbinafine PlaceboNovartisPhase 3
40
Terbinafine hydrochlorideNovartisPhase 3
40
fluconazolePfizerPhase 3
40
AN2718 + AN2718 + AN2718 + AN2718 + AN2718 + AN2718PfizerPhase 1
29
W0027 + PlaceboGSK plcPhase 1
29
Bifonazole spray once daily + Bifonazole spray twice daily + Placebo + Placebo + Lamisil OnceBayerPhase 2
32
Econazole Nitrate Cream, 1% + PlaceboViatrisPhase 3
37
LAS41003 + LAS189961 + LAS189962AlmirallPhase 2
29
Luliconazole Cream 1% + Vehicle CreamBausch HealthApproved
37